Advanced wound care. Distributed by ITG.

Microlyte® is a synthetic antimicrobial matrix containing ionic and metallic silver at low, non-toxic levels, providing a 99.99% reduction of a broad range of microbes on the matrix. Designed to support wound healing by conforming to wound-bed micro-crevices, maintaining a moist healing environment, and sustaining consistent reduction of microbial burden.

• Conforms with transparency to the microtextures of the wound bed
• Sustained antimicrobial activity of ionic silver on the matrix
• Can be used at onset of treatment or in surgery
• Compatible with other wound management technologies

Microlyte® PainGuard™ combines the antimicrobial matrix of Microlyte® with a uniform, unit-dose of lidocaine HCl — providing simultaneous infection control and pain relief. Releases >80% of lidocaine HCl within the first 30 minutes. FDA 510(k) cleared (K211943).

• 99.99% reduction of broad-range microbes on the matrix
• >80% lidocaine HCl release within 30 minutes
• Synthetic, thin, porous matrix of resorbable polymers
• Designed to mimic human ECM

Dual-layer amnion human tissue allograft derived from the amniotic membrane. Serves as a barrier providing protective covering for the wound. Minimally manipulated, preserving natural state properties, FDA compliant. 5-year shelf life.

• Dual-layer amnion construction
• Readily available · easy application
• 5-year shelf life
• FDA compliant — terminally sterilized

Hydrated, dual-layer amnion human tissue allograft derived from the amniotic membrane. Serves as a barrier providing a hydrated protective covering for the wound. Minimally manipulated, FDA compliant. 5-year shelf life.

• Hydrated formulation for moist wound environments
• Dual-layer amnion construction
• 5-year shelf life
• FDA compliant — terminally sterilized

Single-layer amnion human tissue allograft derived from the amniotic membrane. Serves as a barrier providing protective wound covering. Minimally manipulated, FDA compliant. 5-year shelf life.

• Single-layer construction — lighter profile
• Readily available · easy application
• 5-year shelf life
• FDA compliant — terminally sterilized

Triple-layer amnion-chorion-amnion human tissue allograft derived from the amniotic membrane. Provides maximum structural integrity as a barrier and protective covering for complex wounds. Minimally manipulated, FDA compliant. 5-year shelf life.

• Triple-layer amnion-chorion-amnion construction
• Maximum structural protection for complex wounds
• 5-year shelf life
• FDA compliant — terminally sterilized

APIS® is designed to cover and protect wounds, absorb exudate, and create a moist wound environment. Supplied as an all-in-one sheet — ready to apply in minutes, trimmable or foldable, naturally conforming to the wound bed.

• 4–8 week wound closure in clinical studies
• 99.99% bacteria reduction in 24 hours
• Lower pain reported vs. standard of care
• Inflammation reduction and growth factor release
• Established HCPCS code A2010 — reimbursement-ready

Indications: Full & partial thickness wounds, pressure ulcers (stages I–IV), venous stasis ulcers, diabetic ulcers, surgical wounds, traumatic wounds, abrasions, donor site wounds.

The plasma care® generates cold plasma (<40°C) from ambient air, working with reactive oxygen and nitrogen species as therapeutic components. The 2-fold effect: stimulation of wound healing via cytokine release and angiogenesis, plus bactericidal destruction of prokaryotic cell macromolecules — effective against antibiotic-resistant pathogens.

• Effective against MDROs, bacteria, fungi — including antibiotic-resistant strains
• Safe — no tissue damage; suitable for patients with pacemakers
• 1–3 min per wound area; treatment area up to 73 cm² per spacer
• 2–3 treatments per week
• Mobile — 610 g, 16 × 5 cm, 4–6 hrs operating time

Indications: All types of chronic wounds, acute wounds, surgical wounds, entry ports (CVC, IV-lines, drainages, urinary catheters).